Overall, these results indicate that GH promotes EMT in NSCLC cells in a cell-line–dependent manner, and pegvisomant effectively antagonizes both basal and chemotherapy-enhanced EMT marker expression. Here, GH1 is linked to non-small cell lung carcinoma.